ADVFN Logo ADVFN

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Premium IconPremium Help Menu
S&P 500
5,525.21
0.74%
Dow Jones
40,113.50
0.05%
US Dollar vs MXN
19.536
-0.01%
Brent Oil
65.945
-0.12%
Bitcoin
93,549.14
-0.22%
Pepperstone
Advertisement
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Nyxoah SA (NYXH)

  7. Nyxoah SA (NYXH) Noticias

NYXH

Nyxoah (NYXH)

Nyxoah SA
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NYXH
FechaHoraFuenteTítuloSímboloCompañía
16/04/202505:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYXHNyxoah SA
16/04/202501:00GlobeNewswire Inc.Conditional Issuance of SharesNASDAQ:NYXHNyxoah SA
08/04/202500:00GlobeNewswire Inc.Nyxoah Provides Update on FDA Approvable Letter for Genio SystemNASDAQ:NYXHNyxoah SA
01/04/202523:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NYXHNyxoah SA
26/03/202502:00GlobeNewswire Inc.FDA Issues Nyxoah an Approvable Letter for its Genio® SystemNASDAQ:NYXHNyxoah SA
20/03/202517:01Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:NYXHNyxoah SA
20/03/202515:26Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NYXHNyxoah SA
20/03/202515:05Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:NYXHNyxoah SA
13/03/202501:00GlobeNewswire Inc.Nyxoah Reports Fourth Quarter and Financial Year 2024 Financial and Operating ResultsNASDAQ:NYXHNyxoah SA
10/03/202516:05GlobeNewswire Inc.Nyxoah to Release Fourth Quarter and Financial Year 2024 Financial Results on March 13, 2025NASDAQ:NYXHNyxoah SA
03/03/202515:30GlobeNewswire Inc.Nyxoah to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceNASDAQ:NYXHNyxoah SA
19/02/202500:05GlobeNewswire Inc.Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Middle EastNASDAQ:NYXHNyxoah SA
14/02/202513:31Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NYXHNyxoah SA
20/01/202515:30GlobeNewswire Inc.Publication relating to transparency notificationsNASDAQ:NYXHNyxoah SA
13/12/202401:05GlobeNewswire Inc.Nyxoah Announces Commercial Launch of Genio® Innovative Therapy in EnglandNASDAQ:NYXHNyxoah SA
27/11/202415:30GlobeNewswire Inc.Information on the total number of voting rights and sharesNASDAQ:NYXHNyxoah SA
20/11/202415:05GlobeNewswire Inc.Nyxoah to Participate in the Piper Sandler 36th Annual Healthcare ConferenceNASDAQ:NYXHNyxoah SA
19/11/202400:00GlobeNewswire Inc.Invitation to attend the special shareholders’ meeting of the Company to be held on December 19, 2024NASDAQ:NYXHNyxoah SA
06/11/202415:05GlobeNewswire Inc.Nyxoah Reports Third Quarter Financial and Operating ResultsNASDAQ:NYXHNyxoah SA
04/11/202415:45GlobeNewswire Inc.Nyxoah Appoints John Landry as Chief Financial OfficerNASDAQ:NYXHNyxoah SA
22/10/202415:30GlobeNewswire Inc.Nyxoah to Release Third Quarter 2024 Financial Results on November 6, 2024NASDAQ:NYXHNyxoah SA
10/10/202415:00Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:NYXHNyxoah SA
07/10/202416:00GlobeNewswire Inc.Nyxoah Raises $27 Million through its At-the-Market OfferingNASDAQ:NYXHNyxoah SA
27/09/202415:30GlobeNewswire Inc.DREAM Pivotal Study Data Presented at the International Surgical Sleep Society 2024 Educational UpdateNASDAQ:NYXHNyxoah SA
05/09/202415:30GlobeNewswire Inc.Nyxoah to Participate in Upcoming Investor ConferencesNASDAQ:NYXHNyxoah SA
02/09/202415:05GlobeNewswire Inc.Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea DeviceNASDAQ:NYXHNyxoah SA
06/08/202415:05GlobeNewswire Inc.Nyxoah Reports Second Quarter and First Half 2024 Financial and Operating ResultsNASDAQ:NYXHNyxoah SA
29/07/202415:30GlobeNewswire Inc.Nyxoah to Release Second Quarter and First Half 2024 Financial Results on August 6, 2024NASDAQ:NYXHNyxoah SA
15/07/202401:00GlobeNewswire Inc.Nyxoah Appoints Scott Holstine as Chief Commercial OfficerNASDAQ:NYXHNyxoah SA
03/07/202405:30GlobeNewswire Inc.Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment BankNASDAQ:NYXHNyxoah SA
 Showing the most relevant articles for your search:NASDAQ:NYXH

Su Consulta Reciente

NASDAQ
MSFT
Microsoft
COIN
DOGEUSD
Dogecoin
AMEX
XLE
Energy Select Sector SPDR
USI
USTECH100
US Tech 100
NYSE
AXP
American Express
AMEX
XLV
Health Care Select Sector
NYSE
XOM
Exxon Mobil
USOTC
BASFY
BASF (QX)
NASDAQ
TSLA
Tesla
AMEX
XLF
Financial Select Sector
FX
EURMXN
Euro vs MXN
PM
XAUUSD
Gold vs US Dollar
NYSE
NKE
Nike
FX
USDMXN
US Dollar vs MXN
USOTC
RHHBY
Roche (QX)
Delayed Upgrade Clock
ADVFN Logo
México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios